Filing Details

Accession Number:
0001140361-12-042785
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-10-03 17:41:12
Reporting Period:
2012-09-14
Filing Date:
2012-10-03
Accepted Time:
2012-10-03 17:41:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
788920 Pro Dex Inc PDEX Surgical & Medical Instruments & Apparatus (3841) 841261240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478067 John Nicholas Swenson 3033 Excelsior Boulevard, Suite 560
Minneapolis MN 55416
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-09-14 3,362 $1.70 41,874 No 4 L Indirect By AO Partners I, LP
Common Stock Acquisiton 2012-09-18 300 $1.69 42,174 No 4 L Indirect By AO Partners I, LP
Common Stock Acquisiton 2012-09-20 386 $1.69 42,560 No 4 L Indirect By AO Partners I, LP
Common Stock Acquisiton 2012-10-01 2,384 $1.80 44,944 No 4 P Indirect By AO Partners I, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 L Indirect By AO Partners I, LP
No 4 L Indirect By AO Partners I, LP
No 4 L Indirect By AO Partners I, LP
No 4 P Indirect By AO Partners I, LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 172,271 Indirect By Glenhurst Co.
Common Stock 257,506 Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The prices actually paid ranged from $1.69 to $1.70. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
  2. The price in Column 4 is a weighted average price. The prices actually paid ranged from $1.72 to $1.89. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.